Abstract
The increasing availability of individual-level data from clinical trials could allow the relative efficacy of new drugs to be assessed in a robust, cost-effective and timely way.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Atrial Fibrillation / drug therapy
-
Atrial Fibrillation / economics
-
Cost-Benefit Analysis / trends*
-
Drugs, Investigational / economics
-
Drugs, Investigational / therapeutic use*
-
Humans
-
Randomized Controlled Trials as Topic / economics
-
Randomized Controlled Trials as Topic / trends
-
Treatment Outcome*